Prof. Hiroyuki Nakamura: accelerator-based BNCT will be chosen as a primary therapy for early stage cancer

Posted On 2018-12-24 12:00:02

The 18th International Congress on Neutron Capture Therapy was held successfully at the Chang Yung-Fa International Convention Center in Taipei, Taiwan from October 28th to November 2nd, 2018. At this congress, Therapeutic Radiology and Oncology (TRO) had the great honor to invite Prof. Hiroyuki Nakamura from the Tokyo Institute of Technology to have an exclusive interview with us, allowing our readers to know more about the research of albumin-based boron delivery and the future of boron neutron capture therapy (BNCT).

Read More>>